Dividend Aristocrats are among Wall Street's most beloved stocks. Some companies pay dividends, fewer companies manage to ...

Australia's squad for the start of the Ashes series has been named, with one big-name player axed and a potential debutant in the mix to play in Perth. After a lean run of form, Sam Konstas has been ...

Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.

Abbott's $23B Exact Sciences deal adds short-term risk and earnings dilution. Click here to read what this means for ABT ...

In the rush to get at-home tests on the market, they were released with short shelf lives on their packaging. But some have ...

Abbott is buying Exact Sciences, the maker of tests designed to detect early cancers, in a $21 billion deal, a sign of ...

Abbott Laboratories $21 billion deal to acquire cancer test maker Exact Sciences could bolster the company’s diagnostic ...

SAN DIMAS--(BUSINESS WIRE)--At the end of the day, going forward, a new normal that has evolved from generation X is on the runway heading towards a streamlined cloud solution. User generated content ...